Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for August 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
MONDAY, Aug. 31, 2020 (HealthDay News) — A deep learning model based on chest radiograph (CXR) images and data from the electronic medical record (EMR) has better discrimination for smokers at high risk for incident lung cancer than Centers for Medicare & Medicaid Services (CMS) eligibility, according to a study published online Sept. 1 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
FDA Could Green-Light COVID-19 Vaccines Before Clinical Trials Completed
MONDAY, Aug. 31, 2020 (HealthDay News) — Emergency use authorization (EUA) or approval for a COVID-19 vaccine before phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administration, according to the agency’s commissioner, Stephen Hahn, M.D.
Community-Level Factors Explain Some Racial Disparities in COVID-19
MONDAY, Aug. 31, 2020 (HealthDay News) — Community-level factors explain some, but not all, racial and ethnic disparities in COVID-19 rates in Massachusetts, according to a report published online Aug. 27 in Health Affairs.
Lung-Specific Risk Factors Linked to Hip Fracture in Smokers
MONDAY, Aug. 31, 2020 (HealthDay News) — The addition of lung-specific risk factors into fracture risk assessment tools may more accurately predict hip fracture risk in smokers, according to a study published online Aug. 4 in the Journal of Bone and Mineral Research.
Abstract/Full Text (subscription or payment may be required)
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 24 to 28, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Model Says COVID-19 Deaths Could Surpass 317,000 by December
FRIDAY, Aug. 28, 2020 (HealthDay News) — A widely cited model for COVID-19 deaths in the United States predicts a total of 317,000 deaths by December.
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis
Cognitive, Manual Impairment Tied to Unacceptable Inhaler Technique
Vitamin A, D May Aid Asthma Outcomes
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease
Exposure to Air Pollutants Linked to Increased RA Disease Activity
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis
Mesothelioma Diagnoses and Deaths Still Increasing